Company Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Equities
NXTG
IL0004330119
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12/20/12 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10/22/10 |
General Counsel | 53 | 12/20/12 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 01/94/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12/20/12 |
Israel Makov
CHM | Chairman | 85 | 21/11/21 |
Ron Grupel
BRD | Director/Board Member | 73 | 13/14/13 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 12/20/12 |
Orna Dreazen
BRD | Director/Board Member | 69 | 12/20/12 |
Director/Board Member | 59 | 12/20/12 | |
Director/Board Member | 72 | 12/20/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,601,972 | 5,226,508 ( 16.03 %) | 0 | 16.03 % |
Company contact information
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.ilSector
1st Jan change | Capi. | |
---|---|---|
-27.74% | 9.96B | |
-6.47% | 3.03B | |
+31.12% | 3B | |
-14.73% | 2.18B | |
-14.72% | 1.76B | |
+68.09% | 1.42B | |
+22.17% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |